Lv3
241 积分 2021-11-03 加入
Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)
18天前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
22天前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已关闭
Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases
2个月前
已完结
Consensus on the lung cancer management after third-generation EGFR-TKI resistance
2个月前
已完结
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2个月前
已完结
Stratifying risk in oligoprogressive EGFR-mutated non-small cell lung cancer (NSCLC): The role of liquid biopsy
2个月前
已完结
非小细胞肺癌三代表皮生长因子受体酪氨酸激酶抑制剂耐药后诊疗策略专家共识(2025版)
3个月前
已完结
皖公网安备34019202002308
